This company has been marked as potentially delisted and may not be actively trading. Range Cancer Therapeutics ETF (CNCR) Holdings Add Compare Share Share Holdings Stock AnalysisHoldingsRatingsShort InterestTrendsBuy This Stock Top 50 CNCR HoldingsRankCompanyCurrent PriceWeightShares Held1HCMHUTCHMED$14.61-7.2%1.84%8,4142IBRXImmunityBio$2.61-3.0%1.84%43,7763RAPTRAPT Therapeutics$0.88+0.5%1.82%113,7384SMMTSummit Therapeutics$23.47-36.0%1.78%6,3285INBXInhibrx$12.26+2.3%1.77%9,1386YMABY-mAbs Therapeutics$4.10-0.7%1.77%26,7627TSVT2seventy bio$4.98-0.2%1.76%25,7358EXELExelixis$37.43+0.6%1.76%3,4419SNDXSyndax Pharmaceuticals$13.33+0.2%1.75%9,76910BMYBristol-Myers Squibb$47.86-1.7%1.74%2,123 Get the Latest News and Ratings for CNCR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Range Cancer Therapeutics ETF and its competitors with MarketBeat's FREE daily newsletter. 11IMCRImmunocore$30.16-0.7%1.72%4,24112LYELLyell Immunopharma$0.45-3.6%1.72%246,34913BPMCBlueprint Medicines$87.66+1.8%1.71%1,38314ELVNEnliven Therapeutics$18.21-0.5%1.66%6,05515IOVAIovance Biotherapeutics$3.51+4.5%1.66%34,06116ZYMEZymeworks$12.57+0.4%1.66%10,12617SWTXSpringWorks Therapeutics$44.72-0.5%1.64%2,55618ACLXArcellx$63.71-0.4%1.62%1,75119BNTXBioNTech$102.01-15.4%1.62%1,26320REGNRegeneron Pharmaceuticals$602.64+0.5%1.62%18821DAWNDay One Biopharmaceuticals$7.74-2.0%1.61%14,69322NUVLNuvalent$73.49-0.7%1.61%1,65423GERNGeron$1.421.60%73,21124MRKMerck & Co., Inc.$82.83+3.7%1.60%1,34425MRUSMerus$43.57-1.8%1.60%2,69826GMABGenmab A/S$20.59+0.2%1.59%6,12427JANXJanux Therapeutics$31.05-3.2%1.57%4,04328KURAKura Oncology$6.431.57%17,47429IPHAInnate Pharma$2.00-0.5%1.55%62,75230RVMDRevolution Medicines$38.77+0.5%1.55%3,25531LEGNLegend Biotech$34.28+0.1%1.54%3,35832CGEMCullinan Therapeutics$8.141.52%14,10733RCUSArcus Biosciences$8.30-1.3%1.51%13,92234AUTLAutolus Therapeutics$1.33-5.0%1.51%69,99335ERASErasca$1.39-0.7%1.51%87,25136BMEABiomea Fusion$2.19-4.8%1.50%50,55037IDYAIDEAYA Biosciences$19.00-0.4%1.50%6,65938NUVBNuvation Bio$2.131.50%60,95139CRBUCaribou Biosciences$0.77-11.3%1.48%124,88940IMTXImmatics$4.52-3.2%1.47%25,580Warning: “DOGE Collapse” imminent (Ad)Elon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week, President Trump promised to buy a Tesla to help support Musk in the face of a boycott against his company. But according to one research group, with connections to the Pentagon and the U.S. government, Elon's preparing to strike back in a much bigger way in the days ahead.Click here to see what they’re predicting now.41SDGRSchrödinger$26.45+1.2%1.47%5,36842PGENPrecigen$1.50-5.7%1.46%71,56643ARVNArvinas$9.05-1.0%1.45%14,64244NRIXNurix Therapeutics$11.56+0.3%1.43%9,14545BCYCBicycle Therapeutics$8.42-2.1%1.42%12,76446TYRATyra Biosciences$10.04-0.5%1.41%11,86147FATEFate Therapeutics$1.28-5.2%1.40%131,83048AURAAura Biosciences$5.38-2.5%1.38%16,89549ITOSiTeos Therapeutics$7.35-1.5%1.38%17,30850ALLOAllogene Therapeutics$1.55-1.3%1.37%68,858 Geographic ExposureUnited States95.4%Netherlands3.0%Currency ExposureUSD100.0%Sector ExposureHealth Care92.7%Biotechnology2.9%Information Technology1.8%Chemicals1.6%Industry ExposureBiotechnology92.5%Pharmaceuticals3.0%IT Services1.8%Chemicals1.6%SubIndustry ExposureBiotechnology83.5%Pharmaceuticals6.3%Internet Services & Infrastructure1.8%Specialty Chemicals1.6%Coupon Exposure4-61.1%Maturity Exposure5-101.1% Related Companies and Tools Related Companies JPMorgan Healthcare Leaders ETF Portfolio ProShares UltraShort Nasdaq Biotechnology Portfolio First Trust Nasdaq Pharmaceuticals ETF Portfolio Horizon Kinetics Medical ETF Portfolio Global X HealthTech ETF Portfolio Invesco Nasdaq Biotechnology ETF Portfolio F/m Emerald Life Sciences Innovation ETF Portfolio ProShares Ultra Nasdaq Biotechnology Portfolio Invesco Dorsey Wright Healthcare Momentum ETF Portfolio Invesco S&P SmallCap Health Care ETF Portfolio This page (NASDAQ:CNCR) was last updated on 4/25/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredFeds Just Admitted It—They Can Take Your CashHere’s the cold truth: If your money is sitting idle in a bank account, it’s vulnerable. That’s why thousan...Priority Gold | Sponsored"I'm risking my reputation on this"I've discovered something so significant about the 2025 crypto market that I had to put everything else aside ...Crypto 101 Media | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Range Cancer Therapeutics ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Range Cancer Therapeutics ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CNCR Stock Free CNCR Stock Alerts